Verrica Pharmaceuticals, Inc. (VRCA)
7.99
-0.25
(-3.03%)
USD |
NASDAQ |
May 08, 16:00
7.95
-0.04
(-0.50%)
After-Hours: 20:00
Verrica Pharmaceuticals Profit Margin (Quarterly) : -158.6% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Lipocine, Inc. | -3.08K% |
| Cognition Therapeutics, Inc. | -- |
| Corcept Therapeutics, Inc. | -18.92% |
| Assertio Holdings, Inc. | -88.08% |
| Johnson & Johnson | 21.75% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -39.87% |
| Return on Invested Capital | -70.74% |
| Gross Profit Margin (Quarterly) | 72.49% |
| Operating Margin (Quarterly) | -136.4% |
| Return on Net Operating Assets | -153.1% |